WFG
TEVA icon

Windsor Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Windsor Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$3.1M Sell
93,316
-450
-0.5% -$13.9K 1.45% 33
2017
Q1 		$3.01M Buy
93,766
+24,350
+35% +$831K 1.38% 37
2016
Q4 		$2.52M Sell
69,416
-42,990
-38% -$1.72M 1.19% 37
2016
Q3 		$5.17M Buy
112,406
+600
+0.5% +$31.3K 2.43% 17
2016
Q2 		$5.62M Buy
111,806
+5,495
+5% +$293K 2.56% 10
2016
Q1 		$5.69M Buy
106,311
+33,916
+47% +$1.99M 2.6% 10
2015
Q4 		$4.75M Buy
72,395
+192
+0.3% +$11.9K 2.31% 16
2015
Q3 		$4.08M Sell
72,203
-35,919
-33% -$2.33M 1.96% 27
2015
Q2 		$6.39M Sell
108,122
-2,488
-2% -$153K 2.75% 6
2015
Q1 		$6.89M Buy
110,610
+2,426
+2% +$141K 3.09% 3
2014
Q4 		$6.22M Sell
108,184
-774
-0.7% -$43.1K 2.96% 2
2014
Q3 		$5.86M Sell
108,958
-744
-0.7% -$39.4K 2.81% 3
2014
Q2 		$5.75M Sell
109,702
-1,943
-2% -$99.3K 2.81% 3
2014
Q1 		$5.9M Sell
111,645
-174
-0.2% -$8.04K 2.99% 2
2013
Q4 		$4.48M Buy
111,819
+1,701
+2% +$67K 2.48% 12
2013
Q3 		$4.16M Buy
110,118
+3,427
+3% +$134K 2.5% 9
2013
Q2 		$4.18M Buy
+106,691
New +$4.15M 2.65% 4

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Windsor Financial Group's TEVA Position: Q2 2017 in Review

Windsor Financial Group reduced its Teva Pharmaceuticals (TEVA) stake by 0.48% in Q2 2017, selling an estimated $13.9K and leaving 93,316 shares worth $3.1M. The position accounts for 1.45% of the portfolio, ranked #33.

Windsor Financial Group first reported a position in TEVA in Q2 2013 and has held it in 17 quarters since. The position peaked at $6.89M in Q1 2015. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Windsor Financial Group held 93,316 shares of Teva Pharmaceuticals worth $3.1M as of Q2 2017.
  • Windsor Financial Group sold 450 Teva Pharmaceuticals shares in Q2 2017, an estimated $13.9K.
  • Teva Pharmaceuticals made up 1.45% of Windsor Financial Group's portfolio in Q2 2017, its #33 holding.
  • Windsor Financial Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • Windsor Financial Group's Teva Pharmaceuticals position peaked at $6.89M in Q1 2015.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Windsor Financial Group's 13F filing for Q2 2017, filed 3 Aug 2017.